Insurance Dispute Resolution Lawyers

Our Insurance & Reinsurance Dispute Resolution team is a recognised industry leader, having been involved in numerous high-profile disputes. From the latest claims and notification arising from the sub-prime crisis, to the most complicated major catastrophes, as well as perennial market challenges, our team has market-leading experience representing insurers and reinsurers in complex, high-value arbitration, litigation and mediation matters.

Insurance disputes can arise out of insured risks, claims or policy disputes, but insurers are also facing unprecedented regulatory challenges. Our team of dedicated experts combine significant experience with the legal and commercial acumen necessary to obtain a desirable and cost-effective resolution in this dynamic, challenging and highly competitive field.

Our global presence enables us to provide comprehensive, multi-jurisdictional legal advice at the times most critical to our clients.

Our team are experienced in all types of disputes, including:

  • Coverage and allocation
  • Finite risk reinsurance
  • Problems relating to managing general agencies and pools
  • Insurance/reinsurance insolvency litigation
  • Binding authority issues
  • Wording issues and advice

We represent a wide range of clients, including many of the world’s leading reinsurers, insurers and brokers on issues concerning:

  • Facultative
  • Excess
  • Coverage issues
  • Captive disputes
  • Conflicts of laws and forum shopping
  • Special risks
  • Financial lines
  • Directors’ and officers’ liability
  • Errors and omissions (particularly accountants’)
  • Environmental coverage
  • Policy and contract review

Client Experience

Representative Work

Insurance Arbitration

Representing a reinsurer in arbitration against a Bermuda insured where our client was seeking to have the insurance declared void by reason of material non-disclosure

Representing insurers of the Hyatt Regency Grand Cayman

Representing insurers of the Hyatt Regency Grand Cayman in relation to a US$70 million contested insurance claim, which has given rise to multiple proceedings involving three layers of excess insurers in multiple jurisdictions.

More news
Website-Code-BVI
25 May 2026

Back to Basics- Disputes Series

COMPELLING THE INNOCENT: NORWICH PHARMACAL RELIEF IN THE BVI Norwich Pharmacal relief can be a key, strategic tool to assist litigants with early-stage investigation where a BVI company is involved in “wrongdoing” that is the subject of ongoing or prospective litigation either in the BVI or abroad.  A Norwich Pharmacal disclosure order in the BVI is typically made against the registered agent of a “wrongdoer” BVI company, unbeknownst to the company itself, compelling the registered agent to provide information and documentation on the company’s directors, shareholders, ultimate beneficial owners and/or assets.  It is a flexible remedy but it typically enables an applicant party to obtain disclosure to identify the protagonists controlling the “wrongdoer” BVI company and details of its assets necessary in order to pursue their claim or to enforce and execute a judgment. Most frequently, relief is given in aid of foreign proceedings where it is needed to properly plead out a potential claim, to support eventual enforcement of a foreign judgment and/or to obtain or police an injunction.

Appleby-Website-Arbitration-and-Dispute-Resolution
14 May 2026

Arbitrating shareholders’ disputes and beyond – the Mauritian Supreme Court re-affirms its non-interventionist and pro-arbitration stance

On 08 May 2026, the Mauritian Supreme Court, sitting as the panel of Designated Judges appointed under the International Arbitration Act 2008 (IAA), delivered an important judgment in Intermediate Investment Holdings Ltd v Imevbore & Ors 2026 SCJ 186 (IIHL Case). The Supreme Court declined to award costs sought by the Respondents following the Applicant’s withdrawal of an application for an interim injunction.

The Exception To The Rule: Stricter Test Applies Where Granting An Interlocutory Injunction Would Shut Out Trial
28 Apr 2026

The Interplay Between Supervision Applications and Winding Up on the Just and Equitable Ground: Re Atlas Capital Markets LLC

In its recent judgment in Re Atlas Capital Markets LLC [2026] CIGC (FSD) 19, the Grand Court considered itself bound to make a supervision order pursuant to s.131(b) of the Companies Act, notwithstanding that the company was the subject of a pending just and equitable winding up (J&E) petition when its voluntary liquidation was commenced; and rejected an attack on the joint voluntary liquidators’ (JVLs) independence, which was principally based on a misreading of the JVLs’ evidence and lacked any objective foundation. The authors, who successfully represented the JVLs in obtaining the supervision order, discuss this important judgment further below – which is believed to be the first decision on the interplay between supervision applications and J&E proceedings under the Companies Act – and offer their views on the guidance that shareholders petitioning on the just and equitable ground may derive from it in future cases.  The challenge to the JVLs’ independence was rejected on the well-established principles which Doyle J discussed in Re Global Fidelity Bank [2021] 2 CILR 361, and is not discussed in further detail below.

Appleby-Website-BVI1
27 Apr 2026

Back to Basics - Dispute Series

Winding-Up Petitions in the BVI – A Practical Guide For Creditors Applying to appoint a BVI liquidator is one of the most cost effective and efficient tools available to creditors who want to recover debts or liabilities from BVI companies and is often a go-to strategy where simpler methods of debt collection have failed. Once appointed, a liquidator has a broad range of immediate powers including the ability to take possession and control of all of the company’s assets. In this guide, we highlight the process and the key principles for creditors to consider prior to and during the liquidator appointment process.